Physician

Ali H Haidar, M.D.

According to 2025 Medicare claims, Ali Haidar, M.D. (NPI: 1104892058) practices pulmonary disease in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from St. Clair, MI. This provider's primary affiliated billing organization is MCLAREN PORT HURON (NPI: 1619355930; TIN: 38-1369611) and primary practice location at 48060-3511. Haidar is affiliated with the McLaren High Performance Network, LLC (ACO ID: A3317), Mosaic ACO (ACO ID: A5033), Aledade 155 National MSSP (ACO ID: A5358), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Haidar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 749 traditional Medicare patients, billed 3,023 HCPCS/CPT codes, and received $212,580 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 5,670 prescription claims across 699 beneficiaries totaling $1,669,496 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,160 claims. Open Payments data shows 4 records totaling $67. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $368,153 to $212,580. In contrast, Part D prescription costs have risen steadily, from $856,506 to $1,669,496. For DME billing, this smaller-volume category declined steadily, from $108,671 to $44,431.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,280	5,868	$368,153
2016	1,292	5,348	$343,440
2017	1,218	4,384	$306,695
2018	1,245	4,665	$295,156
2019	1,173	4,147	$264,103
2020	1,042	3,275	$244,947
2021	956	3,199	$245,692
2022	818	2,631	$186,787
2023	809	2,752	$190,703
2024	749	3,023	$212,580

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	648	6,787	$856,506
2016	635	6,511	$944,931
2017	662	6,325	$1,082,026
2018	634	6,049	$1,149,098
2019	618	5,713	$1,250,375
2020	587	5,731	$908,396
2021	573	5,225	$960,351
2022	576	5,058	$1,163,429
2023	648	5,436	$1,628,586
2024	699	5,670	$1,669,496

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	625	2,806	$116,274
2016	440	2,396	$94,928
2017	434	2,019	$66,648
2018	531	2,436	$120,649
2019	526	2,521	$97,127
2020	421	2,256	$81,405
2021	308	1,885	$83,997
2022	264	1,415	$54,556
2023	196	1,147	$47,313
2024	242	1,160	$46,994

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	205	222	$105
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	242	664	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	464	749	$82
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	178	249	$13
94060	Test to measure expiratory airflow and volume changes before and after medication administration	215	220	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	643	27,390	$563,299
Prolastin C	Alpha-1-Proteinase Inhibitor	45	1,232	$522,225
Eliquis	Apixaban	69	3,630	$66,711
Symbicort	Budesonide/Formoterol Fumarate	176	8,970	$61,687
Spiriva Respimat	Tiotropium Bromide	77	3,330	$54,908

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	41	315	$27,391
E1392	Portable oxygen concentrator, rental	Y	30	214	$7,058
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	40	125	$2,968
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	N	32	120	$2,118
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	12	$1,981

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$67	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali H. Haidar, M.D.?

Tedicare shows public-source Medicare data for Ali H. Haidar, M.D. (NPI 1104892058), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali H. Haidar, M.D. have ACO affiliation data?

Ali H. Haidar, M.D. is shown with ACO affiliation data for McLaren High Performance Network, LLC (MSSP, ACO ID A3317), Mosaic ACO (MSSP, ACO ID A5033), Aledade 155 National MSSP (MSSP, ACO ID A5358), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Ali H. Haidar, M.D.?

Ali H. Haidar, M.D. is linked to MCLAREN PORT HURON (billing NPI 1619355930) in the available physician profile data.

Does Ali H. Haidar, M.D. have Open Payments data?

Ali H. Haidar, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.